• Home
  • About Us
    • The Rhizen Journey
    • Leadership Team
    • What We Do
    • Our Network
  • Our Science
    • Oncology
    • The PI3K Journey
    • Onco Inflammation
    • Clinical Trials
    • Scientific Advisory Board
  • Our Pipeline
  • Partnering
    • Partnering Strategy
    • Our Partners
  • News and Events
    • From the CEO’s Desk
    • Latest News
    • Recent Publications
    • The Rhizen – Blog
  • Contact Us

Innovative Medicines

Developing next generation medicines
that will lead the fight against cancer & inflammation.

Breaking News

Rhizen Announces US FDA IND Acceptance for RP7214 in SARS-CoV-2 Infection More…

Tenalisib Poster Presentation at ASH 2020  more…

CANCER CELLS EVOLVE, SO DOES OUR SCIENCE

Relentless and innovative thinking that keeps our science one step ahead, always!

Oncology

Racing Ahead to Beat Cancer

PI3K Journey

Best-in-Class PI3K Inhibitors

Pipeline

100% IP Ownership

Partnerships

Driving successful collaborations

OUR STORY

The Rhizen Journey!

Our Journey To Be A Leading Oncology-focused Specialty Company Developing Differentiated Products Through Cutting-edge Science and Strategic Partnerships Started in 2008.

Discover more
0 +
TARGETS

Novel programs targeting multiple hallmarks of cancer

0 +
Trials

Assessing the safety and efficacy of our novel pipeline

0 +
PATENTS

Accumulated from dedicated research efforts for the last 12 years

Our Team

We Are All In To Make It Possible

bios_image_edited-1

Swaroop Vakkalanka, PhD

Founder & CEO

Proven and seasoned senior leadership team with expertise spanning the entire discovery-development-commercialization value chain

Meet Our Team
OUR PARTNERING STRATEGY

Flexible Global and Regional Approach

Progress in-house assets through clinical POC and out-license to global partners for large markets

In-license differentiated assets for development and commercialization

Build a pipeline of specialty assets across the oncology and onco-inflammation space
Partner With Us
pricing Plans

The Best Solutions for Our Clients

Contact Us

    img_box_30_orange

    Rhizen Pharmaceuticals AG, Steinentorstrasse 23,
    4051 Basel Switzerland.
    Fax +41 32 580 0175

    Rhizen Pharmaceuticals Inc
    726 US Highway 202 Ste 320 # 396
    Bridgewater, NJ 08807-2737

    img_box_13

    info@rhizen.com​

    twitter
    linkedin
    • About Us
    • Our Science
    • Our Pipeline
    • Partnering
    • Terms & Conditions
    • Data Protection & Privacy Policy
    • The Rhizen Journey
    • What We Do
    • Leadership Team
    • Key Strengths
    • News and Events

    © 2021 . All Rights Reserved.